FDA BLA · BLA103795

ENBREL

etanercept

Sponsor: IMMUNEX

What this page does not claim

A drug page is a reference view of public FDA data (Drugs@FDA), reproduced as published. SPEQ is not affiliated with the FDA, adds no interpretation to the record, and nothing here is medical, legal, or regulatory advice.

APPLICATION
BLA103795
TYPE
BLA
ORIGINAL APPROVAL
1998-11-02
LATEST ACTION
2026-10-14
ROUTE
SUBCUTANEOUS
DOSAGE FORM
SYRINGE, VIAL
MARKETING STATUS
Prescription

Products

ENBRELPrescription
ETANERCEPT 50MG/ML · SYRINGE
ENBRELPrescription
ETANERCEPT 25MG/VIAL · VIAL · SUBCUTANEOUS

Approval history

2026-10-14Labeling · Supplement 5610 · standard — Letter ↗AP
2026-01-30Labeling · Supplement 5605 · standard — Letter ↗AP
2025-12-10Labeling · Supplement 5604 · standard — Letter ↗AP
2025-06-18Labeling · Supplement 5603 · standard — Label ↗AP
2024-09-12Labeling · Supplement 5600 · standard — Label ↗AP
2024-07-22Labeling · Supplement 5598 · standard — Letter ↗AP
2024-07-22Labeling · Supplement 5599 · standard — Letter ↗AP
2024-07-22Labeling · Supplement 5597 · standard — Letter ↗AP
2023-10-18Efficacy · Supplement 5595 · standard — Letter ↗AP
2023-06-09Labeling · Supplement 5594 · standard — Letter ↗AP
2022-08-16Labeling · Supplement 5591 · standard — Letter ↗AP
2022-06-17Labeling · Supplement 5590 · standard — Letter ↗AP
2021-02-26Labeling · Supplement 5582 · standard — Label ↗AP
2020-03-05Labeling · Supplement 5574 · standard — Label ↗AP
2020-03-05Manufacturing (CMC) · Supplement 5577 · unknown — Letter ↗AP
2019-02-14Labeling · Supplement 5571 · standard — Letter ↗AP
2018-10-03Labeling · Supplement 5569 · standard — Label ↗AP
2018-05-25UNKNOWN · Supplement 5563 · standard — Letter ↗AP
2018-05-25Labeling · Supplement 5564 · standard — Letter ↗AP
2018-05-11Labeling · Supplement 5565 · standard — Letter ↗AP
2017-11-22Efficacy · Supplement 5559 · standard — Letter ↗AP
2017-10-06Manufacturing (CMC) · Supplement 5561 · standard — Label ↗AP
2017-09-14Efficacy · Supplement 5556 · standard — Label ↗AP
2017-07-11Labeling · Supplement 5551 · standard — Label ↗AP
2016-11-04Efficacy · Supplement 5552 · standard — Letter ↗AP
2015-03-25Labeling · Supplement 5548 · standard — Label ↗AP
2015-03-20Supplement · Supplement 5532 — Label ↗AP
2013-11-15Labeling · Supplement 5531 · standard — Letter ↗AP
2012-12-10Labeling · Supplement 5507 · standard — Label ↗AP
2012-12-04Labeling · Supplement 5503 · standard — Label ↗AP
2011-12-22Labeling · Supplement 5484 · standardAP
2011-11-29Labeling · Supplement 5462 · standardAP
2011-09-07Labeling · Supplement 5475 · standard — Letter ↗AP
2011-08-10Labeling · Supplement 5474 · standardAP
2011-01-25Labeling · Supplement 5431 · standard — Letter ↗AP
2010-11-18Labeling · Supplement 5415 · standard — Label ↗AP
2010-10-13Labeling · Supplement 5445 · standard — Letter ↗AP
2010-09-29Labeling · Supplement 5443 · standard — Letter ↗AP
2010-07-29Labeling · Supplement 5437 · standard — Letter ↗AP
2010-07-20Labeling · Supplement 5391 · standard — Letter ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Biologics industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. Browse every approval SPEQ tracks →